A first-in-human study of CD123 NK cell engager SAR443579 in relapsed or refractory acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or high-risk myelodysplasia.Anthony S. Stein, Ashish Bajel, Abhishek Maiti et al.|Journal of Clinical Oncology|2023Cited by 12
P494: A FIRST-IN-HUMAN STUDY OF CD123 NK CELL ENGAGER SAR443579 IN RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OR HIGH RISK-MYELODYSPLASIAAnthony S. Stein, Ashish Bajel, Mojca Jongen‐Lavrencic et al.|HemaSphere|2023Cited by 2